iOncologi
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2691 NW 138th Ter, Gainesville, Florida,...Phone Number
(352) 559-5100Website
www.ioncologi.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About iOncologi
iOncologi, Inc. is a biotechnology company focused on developing transformative immunotherapy treatments for solid tumor cancers. They are advancing multiple groundbreaking immune therapies, including IONC201 and IONC101, aimed at reprogramming the tumor microenvironment and enhancing anti-tumor immunity. The company serves a diverse client base, including patients with aggressive cancers like glioblastoma and pediatric high-grade glioma, participating in ongoing clinical trials. With a strong emphasis on innovative treatment paradigms, iOncologi collaborates with leading researchers to pioneer stem cell-based therapies and personalized immunotherapeutics.Explore more
iOncologi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is iOncologi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if iOncologi is spiking on competitors!
Earning: See what the market has to say on iOncologi recently announced quarterly report
Funding: Get notified immidiatlly once iOncologi has new funding data
Check if iOncologi has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
iOncologi, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at iOncologi
Product Launch: Get notified when iOncologi launches new products
Click to see if iOncologi had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined iOncologi as Masked Content
Find more new buyers
Compare Similar Companies to iOncologi
Compare insights from companies similar to iOncologi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
iOncologi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
iOncologi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about iOncologi.
iOncologi Tech Stack
A closer look at the technologies used by iOncologi
Most Recent Scoops
Project
Intellectual Property, Legal Affairs, Healthcare Operations, Healthcare Technology
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Partnership
Partnership
iOncologi News & Media
iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors
GAINESVILLE, Fla., March 17, 2025 /PRNewswire/ -- iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its Board of Directors....iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors
GAINESVILLE, Fla, March 14, 2025 /PRNewswire/ -- iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, today announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor targeted...Immunomic Therapeutics Announces Collaboration With iOncologi
ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”) a privately held clinical-stage biotechnology company focused on advancing its proprietary nucleic acid immunotherapy platform, announced today an exclusive option to license or acquire a series of innovative technologies in the immuno-oncology space from iOncologi, Inc., (“iOi”). Preclinical studies led by iOi Co-Founders, Drs. Duane Mitchell and Catherine Flores, have demonstrated that resistance to immune checkpoint inhib
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding iOncologi
Sign Up For FreeTo access detailed company insights
iOncologi, Inc. is a biotechnology company focused on developing transformative immunotherapy treatments for solid tumor cancers. They are advancing multiple groundbreaking immune therapies, including IONC201 and IONC101, aimed at reprogramming the tumor microenvironment and enhancing anti-tumor immunity. The company serves a diverse client base, i... Read More
